Role of liver biopsy in the management of liver dysfunction after hematopoietic stem-cell transplantation in a hepatitis B virus-prevalent patient population

Transplantation

Volumn 76, Issue 1, 2003, Pages 169-176

  Ma, Shing Yan ^a   Au, Wing Yan ^a   Ng, Irene O L ^a   Lie, Albert K W ^a   Leung, Anskar Y H ^a   Liang, Raymond H S ^a   Lau, George K K ^a   Kwong, Yok Lam ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CEFTIBUTEN; CYCLOSPORIN A; FAMCICLOVIR; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; INTERFERON; LAMIVUDINE; METHOTREXATE; RIBAVIRIN;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL FEATURE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE; VIRUS CARRIER; VIRUS REACTIVATION;

ADOLESCENT; ADULT; BIOPSY; FEMALE; GRAFT VS HOST DISEASE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HONG KONG; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA; LIVER; LIVER DISEASES; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLATELET COUNT; PREVALENCE; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION;

EID: 0038638389     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000072809.22740.A8     Document Type: Article

References (30)

1. Farthing MJ, Clark ML, Sloane JP, et al. Liver disease after bone marrow transplantation. Gut 1982; 23: 465-474.
2. McDonald GB, Shulman HM, Sullivan KM, et al. Intestinal and hepatic complications of human bone marrow transplantation: Part 1. Gastroenterology 1986; 90: 460-477.
3. McDonald GB, Shulman HM, Sullivan KM, et al. Intestinal and hepatic complications of human bone marrow transplantation: Part 2. Gastroenterology 1986; 90: 770-784.
4. Forbes GM, Davies JM, Herrmann RP, et al. Liver disease complicating bone marrow transplantation: A clinical audit. J Gastroenterol Hepatol 1995; 10: 1-7.
5. Lebree D, Goldfarb G, Degou C, et al. Transvenous liver biopsy: An experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology 1982; 83: 338-340.
6. McAfee JH, Keeffe EB, Lee RG, et al. Transjugular liver biopsy. Hepatology 1992; 15: 726-732.
7. Shulman HM, Gooley T, Dudley MD, et al. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995; 59: 1015-1022.
8. Carreras E, Granena A, Navasa M, et al. Transjugular liver biopsy in BMT. Bone Marrow Transplant 1993; 11: 21-26.
9. Liang R, Lau GK, Kwong YL. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: A review of the problem. J Clin Oncol 1999; 17: 394-398.
10. Hoofnagle JH, Dusheiko GM, Schafer DF, et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96: 447-449.
11. Parienete EA, Goudeau A, Dubois F, et al. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation. Dig Dis Sci 1988; 33: 1185-1191.
12. Reed EC, Myerson D, Corey HT, et al. Allogeneic marrow transplantation in patients positive for hepatitis B surface antigen. Blood 1991; 77: 195-200.
13. Ustun C, Koc H, Karayalacin S, et al. Hepatitis B virus infection in allogenic bone marrow transplantation. Bone Marrow Transplant 1997; 20: 289-296.
14. Lau GK, Leung YH, Fong DY, et al. High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation. Blood 2002; 99: 2324-2330.
15. Woo PC, Lo SK, Yuen KY, et al. Detection of CMV DNA in bone marrow transplant recipients: Plasma versus leucocyte polymerase chain reaction. J Clin Pathol 1997; 50: 231-235.
16. Strasser SI, Shulman HM, Flowers ME, et al. Chronic graft-versus-host disease of the liver: Presentation as an acute hepatitis. Hepatology 2000; 32(6): 1265-1271.
17. Fujii N, Takenaka K, Shinagawa K, et al. Hepatic graft-versus-host disease presenting as an acute hepatitis after allogenic peripheral blood stem cell transplantation. Bone Marrow Transplant 2001; 27: 1007-1010.
18. Malik AH, Collins RH Jr, Saboorian MH, et al. Chronic graft-versus-host disease after hematopoietic cell transplantation presenting as an acute hepatitis. Am J Gastroenterol 2001; 96: 588-590.
19. Kim BK, Chung KW, Sun HS, et al. Liver disease during the first post-transplant year in bone marrow transplantation recipients: Retrospective study. Bone Marrow Transplant 2000; 26: 193-197.
20. Strasser SI, Myerson D, Spurgeon CL, et al. Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10-year follow-up. Hepatology 1999; 29: 1893-1899.
21. Ustun C, Ozcan M, Gurman G. Differences in liver pathology and clinical outcome between two patients with hepatitis B virus and graft versus host disease. Pathol Oncol Res 1999; 3: 229-232.
22. Shulman HM, Sharma P, McDonald GB. Discriminant analysis of liver histology in graft-versus-host disease. Lab Invest 1985; 52: 61A.
23. Davies SE, Portmann BC, O'Grady JG, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13: 150-157.
24. Akpek G, Boitnott JK, Lee LA, et al. Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood 2002; 100: 3903-3907.
25. Boeckh M, Gooley TA, Myerson D, et al. Cytomegalovirus pp65 antigenaemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic bone marrow transplantation: A randomized double-blind study. Blood 1997; 88: 4063-4071.
26. Stanley-AJ, Haydon GH, Piris J, et al. Assessment of liver histology in patients with hepatitis C and normal transaminase levels. Eur J Gastroenterol Hepatol 1996; 8: 869-872.
27. Lau JYN, Davis GL, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501-1504.
28. Magrin S, Craxi A, Fabiano C, et al. Hepatitis C viremia in chronic liver disease: Relationship to interferon-alpha or corticosteroid treatment. Hepatology 1994; 19: 273-279.
29. Nousbaum JP, Pos S, Nalpas B, et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122: 161-168.
30. Perrillo RP. The role of liver biopsy in hepatitis C. Hepatology 1997; 26(suppl 1): 57S-61S.